TRAIL is a ligand involved in initiating apoptosis that has previously been implicated in atherosclerosis.33–35 Our current work extends on this previous work by use of genetic data that supports that higher circulating TRAIL concentrations causally increase coronary artery disease risk, further implicating TRAIL as a therapeutic target. This evidence concerns the gene TNFSF10 and coronary artery disorder.